Summary: Glia perform several energy-dependent func tions that may aid neuronal survival under pathological conditions. Glycogen is the major energy reserve in brain, and it is localized almost exclusively to astrocytes. Using murine cortical cell cultures containing both glia and neu rons, we examined the effect of altered glial glycogen stores on neuronal survival following glucose depriva tion. As previously reported, cultures exposed for several hours to media lacking glucose developed widespread neuronal degeneration without glial degeneration. If glial astrocyte glycogen content was increased to 2-3 times Astrocytes perform multiple functions essential for the normal activity of neurons in the brain. In addition to providing mechanical support and trophic factors (Bunge and Waksman, 1985) , astro cytes maintain homeostasis of the brain extracellu lar fluid (ECF). Astrocytes are largely responsible for the uptake and catabolism of excitatory amino acids and other neurotransmitters (Ericinska et aI., 1986; Hertz, 1979; Varon and Somjen, 1979) , and for the uptake and redistribution of K + (Hertz, 198 1; Jendelova and Sykova, 199 1). Astrocytic am monia fixation provides the only mechanism other than diffusion for clearing brain ammonia (Cooper and Lai, 1987) . Astrocytes may also play an impor-
control levels by a 24-h pretreatment with 1 11M insulin or 0.5 mM methionine sulfoximine (MSO), glucose depriva tion-induced neuronal degeneration was attenuated. These protective effects were blocked if glycogen levels were reduced back to control levels by a 30-min exposure to 1 mM dibutyryl cyclic AMP or 20 11M norepinephrine prior to glucose deprivation. Astrocyte glycogen stores may be an important factor influencing neuronal survival under conditions of energy substrate limitation. Key Words: Excitatory amino acid-Glucose-Glycogen Insulin-Ischemia-Methionine sulfoximine.
tant role in the regulation of ECF osmolality and pH (Hertz, 198 1; Walz, 1989) . They export metabolic intermediates including lactate (Walz and MukeIji, 1988) and pyruvate (Passonneau et aI., 1978) that may be metabolized by neighboring neurons in the absence of other available substrates (Selak et aI., 1985; Schurr et aI., 1988) . These metabolic interac tions may be facilitated by physical isolation of neu ronal processes and synapses by glial membranes (Harris et aI., 1989; Wenzel et aI., 199 1) .
Growing evidence suggests that changes in ECF composition, including in particular prolonged ele vations in excitatory amino acids, may contribute to neuronal death after brain hypoxia-ischemia or hy poglycemia (Siesj6 and Bengtsson, 1989; Choi, 1990) . Since the ability of astrocytes to take up ex citatory amino acids and otherwise maintain ECF homeostasis is energy dependent, astrocyte energy reserves may be an important factor in determining the extent of neuronal death associated with these pathological conditions. The major energy reserve in brain is glycogen (Lowry et aI., 1964) , accounting for about 65% of ATP that can be generated under ischemic conditions. Almost all of this glycogen is localized to astrocytes, with other glial elements and neurons having minimal stores (Koizumi, 1974; Phelps, 1975; Cataldo and Broadwell, 1986) .
Astrocytes have previously been shown to pro tect cultured neurons from degeneration induced by anoxia (Vibulsreth et al., 1987) . In the present study we used murine cortical cell cultures containing both neurons and astrocytes to investigate the role of astrocyte glycogen stores in supporting neuronal survival during glucose deprivation.
MATERIALS AND METHODS

Cortical cell culture
Glia-confluent cortical cultures were prepared as de scribed by Rose et al. (1991) , by plating dissociated em bryonic mouse cortices onto established glia monolayers. In brief, cerebral cortices taken from mouse pups on post natal day I were separated from meninges and dissociated with trypsin. The cells were suspended in Eagle's mini mal essential medium (MEM, supplied glutamine-free) containing 10% fetal calf serum (FCS), 10% horse serum (HS), 2 mM glutamine (GLN), and 10 ng/ml epidermal growth factor (Sigma, St. Louis, MO, U.S.A.), and plated at a density of 0.5 hemispheres per Falcon Primaria 24-well plate (Becton-Dickenson, Oxnard, CA, U.S.A.). The cultures were kept in a humidified 5% CO2 incubator until confluency, generally day in vitro (d.i.v.) 12-16. Cortices from embryonic day 15 (E I 5) mouse embryos were then dissociated with trypsin, suspended in MEM containing 2 mM GLN, 10% FCS, and 10% HS, and plated onto the confluent glial layer. Cytosine arabinoside (10 j-lM) was added after 5-7 days. Forty-eight hours later the medium was exchanged with fresh MEM containing 2 mM GLN and 5% FCS. These cultures were used for biochemical determinations and glucose deprivation experiments at d.i.v. 14-16.
Glia-poor cultures were prepared by suspending disso ciated E15 mouse cortical cells in MEM with 2 mM GLN and 5% FCS and plating onto polY-D-lysine-treated cul ture dishes. Two days after plating, these cultures were exposed to 10 j-lM cytosine arabinoside for 48 h. On d.i.v. 4 this medium was exchanged with a glia-conditioned MEM containing 5% FCS and 2 mM GLN. These cul tures were used for biochemical determinations on d.i.v. 14.
Immunocytochemistry
Neuron-specific enolase (NSE) and glial fibrillary acidic protein (GF AP) were stained with the avidin-biotin horseradish peroxidase technique. On d.i. v. 12, represen tative cultures were fixed for 20 min in phosphate buffered saline (PBS) containing 4% paraformaldehyde. The fixative was removed and cultures incubated at room temperature for 2 h with the anti-NSE antibody (Dako, Carpinteria, CA, U.S.A.) diluted 1: 1500 or the anti-GFAP antibody (ICN, Costa Mesa, CA, U.S.A.) diluted 1:500 in a solution of 2% horse serum, 0.2% Triton X-100, 0.1% bovine serum albumin (BSA), and 0.02% sodium azide in PBS. The antibodies were removed and the cells reacted for 1 h with biotinylated horse anti-mouse antibody (Elite Vectastain Kit, Vector Laboratories, Burlingame, CA, U.S.A.) diluted 1 :200 in HS-PBS. Cultures were placed for I h in the avidin-horseradish peroxidase solution pre pared according to the manufacturer's instructions and exposed to a fresh solution of diaminobenzidine in PBS. Hydrogen peroxide was added to a final concentration of 0.005% and after incubation for 20 min the cells were washed in PBS.
Manipulation of glycogen levels
At d.i.v. 12 the culture medium was partially ex changed with glucose-free MEM to achieve a final glu cose concentration of 2 mM. On the following day the medium glucose was raised to 5 mM, and indicated cul tures also received I j-lM insulin or 0.5 mM methionine sulfoximine (MSO). These agents are known to increase glial glycogen content, particularly when presented simul taneously with an increase in medium glucose concentra tion (Prasannan and Subrahmanyam, 1968; Swanson et aI., 1989; Hevor and Delorme, 1991) . The cultures were used for biochemical determinations or glucose depriva tion experiments after 24 h incubation. Some of these cultures were also exposed to 20 j-lM norepinephrine (NE) or 1 mM dibutyryl cAMP (dBcAMP), agents known to decrease glial glycogen content (Opler and Makman, 1972; Subbarao and Hertz, 1990) , for 30 min immediately before use. All reagents were added from 50x or 100x stock solutions prepared in water, except insulin which was stored at 1 ,000 x (1 mM) in 0.1% albumin. The acidic MSO stock was brought to neutral pH prior to use.
Glycogen and glucose measurements
Cultures were removed from the incubator and imme diately washed once with ice-cold HEPES buffered iso tonic saline and dissolved in cold 0.1 N NaOH. Aliquots were taken for protein determination by the method of Lowry et al. (1951) . The remainder was acidified with HCI and assayed for glycogen content by the amylo-a-1 ,4-a-l ,6-glucosidase procedure of Passonneau and Lau derdale (1974) . All values were calculated as nmol glu cosyl equivalents. Glucose concentration of culture me dia was measured using the same assay procedure but omitting the amyloglucosidase digestion.
Glucose deprivation
Glucose deprivation studies were performed in glial confluent cortical cultures. The cultures were washed 5 times with I ml glucose-free and glutamine-free MEM to achieve a final measured glucose concentration of less than 2 mM. One minute was allowed between washes to allow egress of intracellular glucose, and 0.2 ml was left after each wash to minimize trauma to the neurons. After the final wash the medium volume was reduced to 0.2 ml and the cells were returned to the incubator. When the majority of neurons exhibited swelling by phase contrast microscopy, usually after 3-4 h, concentrated glucose was added to the cultures to produce a final concentration of 5 mM. Sham wash cultures were brought to 5 mM glucose immediately after the repeated exchanges with glucose-free medium.
Assessment of neuronal cell death
Neuronal death was quantified 24 h after glucose dep rivation by measuring the amount of lactate dehydroge nase (LDH) released into the culture medium (Koh and Choi, 1987) . Measured LDH values were corrected by subtracting the small amount of LDH present in sister cultures subjected to sham wash, and expressed as per cent of control cultures (not subjected to any pharmaco logic manipulation) in the same 24-well plate. All cultures were also inspected by phase contrast microscopy. The morphological estimate of neuronal death correlated well with the LDH activity measured in the culture media. As previously noted (Monyer and Choi, 1990) , glial cells did not show evidence of injury after these periods of glucose deprivation, or even when glucose deprivation was ex tended to 12 h (Swanson and Choi, unpublished results) .
RESULTS
Immunocytochemical staining of "g lia confluent" and "glia-poor" cultures confirmed a major difference in the number of astrocytes in the two preparations. Staining of the "glia-confluent" cortical cell cultures showed clusters of NSE positive neurons resting among a confluent layer of GFAP-positive astrocytes (Fig. 1a,b) . In "glia poor" cultures, the majority of cells exhibited the morphology and NSE staining of neurons (Fig. 2a) . GFAP-positive cells were sparsely distributed among the neurons (Fig. 2b) .
Glycogen content was measured in both the glia confluent and glia-poor culture preparations 24 h after exchange of the culture medium with fresh medium. Glycogen content in the glia-confluent cul tures was 51 ± 10 nmol glucosyl equivalents per mg protein. This value increased about threefold when 0.5 rnM MSO or 1 fLM insulin was added with the fresh medium (Fig. 3) . In glia-poor cultures the gly cogen content was less, 12 ± 9 nmol per mg protein, and unlike the glia-confluent cultures there was lit tle increase in glycogen content after incubation with MSO or insulin (Fig. 3) .
Incubation with 20 fLM NE or 1 rnM dB cAMP for 40 min reduced the glycogen content of the glia confluent cultures to about 50% of control values (Fig. 4) . NE and dBcAMP also lowered glycogen content in cultures when glycogen content had been previously increased by incubation with insulin or MSO (Fig. 4) .
Glucose deprivation for 3 to 4 h caused a submax imal neuronal injury, typically destroying about half the neurons in the glial-confluent cultures. Preincu bation of the cultures with 1 fLM insulin partially attenuated the neuronal death. This was qualita tively gauged by examining neuronal morphology under phase-contrast microscopy, and quantified by measuring LDH efflux (Fig. 5) . The neuropro· tective effect of insulin was prevented when the in- sulin-treated cultures were exposed to 20 f.LM NE or 1 mM dBcAMP for 30 min before onset of glucose deprivation (Fig. 5) . Preincubation with 0.5 mM MSO produced a neuroprotective effect similar to that produced by insulin, also prevented by NE or dBcAMP. In cultures not previously treated with insulin or MSO, exposure to NE of dBcAMP had little potentiating effect on the submaximal neuro nal injury resulting from glucose deprivation. We considered the possibility that preincubation with insulin or MSO might decrease neuronal LDH content, thus leading to an underestimate of glucose deprivation-induced neuronal damage. To address this possibility, total neuronal LDH content was de termined by measuring LDH efflux after a 24-h ex posure to 100 f.LM N-methyl-D-aspartate (NMDA), an exposure sufficient to destroy >90% of the neu ronal population without causing glial damage (Koh and Choi, 1988) . Neither insulin nor MSO treatment caused appreciable changes in total neuronal LDH content (Fig. 6) . The LDH release resulting from the near-total neuronal death after NMDA exposure was about twice the LDH release typically resulting from 3 to 4 h of glucose deprivation.
DISCUSSION
The central finding of the present study is a cor relation in murine cortical cell cultures between the manipulated glycogen content-which we assume is localized to astrocytes-and neuronal vulnerability to glucose deprivation. Specifically, cultures treated with insulin or MSO showed both increased astrocyte glycogen levels and reduced neuronal damage following several hours' exposure to me dium lacking glucose.
Two lines of evidence support our assumption that measurements of total culture glycogen content reflected stores in astrocytes, not neurons. First, cortical astrocytes in vivo and in culture are known to contain substantial amounts of glycogen (Cataldo and Broadwell, 1986; Rosenberg and Dichter, 1987) whereas neurons both in adult brain (Koizumi, 1974; Phelps, 1975; Cataldo and Broadwell, 1986) and fetal brain (Bruckner and Biesold, 198 1) have negligible glycogen stores. Second, we observed much higher glycogen levels in glial-confluent cul tures containing both NSE-positive neurons and GF AP-positive astrocytes than in glial-poor cul tures containing predominantly NSE-positive neu rons. It is noteworthy that exposure to insulin or MSO did not detectably affect the low levels of gly cogen found in glial-poor cultures, consistent with an idea that these agents selectively increase glyco gen stores in astrocytes. Insulin and MSO affect glycogen metabolism by independent mechanisms. Insulin acts at the level of glycogen synthetase kinase (Siesjo, 1978) , induc ing an increased ratio of the active to inactive forms of glycogen synthetase. Although neurons also con tain the enzymes required for glycogen metabolism, levels are low relative to glia (Knull and Khandel wahl, 1982; Reinhart et aI., 1990) . MSO causes an irreversible inhibition of glutamine synthetase (Rao and Meister, 1972) . Glutamine synthetase, like gly cogen, is localized in brain primarily to astrocytes , 1977) , and evidence suggests that the glycogen accumulation caused by MSO may be a secondary consequence of glu tamine synthetase inhibition (Swanson et al., 1990a) . MSO administration to rats in vivo causes brain glycogen accumulation only in glia (Phelps, 1975) .
We acknowledge that the observed neuroprotec tive effect of MSO and insulin might reflect contri butions from effects other than on astrocyte glyco gen stores. In particular, MSO inhibition of glu tamine synthetase blocks glutamine production in astrocytes, an effect which might affect neuronal survival under pathological conditions (Swanson et aI., 1990b) . In brain, MSO lowers extracellular glu tamine (Tews and Stone, 1964) , a major precursor for neurotransmitter glutamate (Bradford et al., 1978; Somers and Beckstead, 1990) . In the present study, however, glutamine was excluded from the media of all cultures during glucose deprivation, and de novo synthesis of glutamine was limited by the absence of glucose and glutamate in the medium CONTROL INSULIN MSO (Waniewski and Martin, 1986; Yudkoff et aI., 1988; Zielke et aI., 1989) . The fact that two independent methods for augmenting astrocyte glycogen stores had similar neuroprotective actions supports the lead hypothesis that the latter effect is due to the former mechanism. Furthermore, as shown in Fig. 5 , the neuropro tective effects of both agents can be abolished by brief exposure to NE or dB cAMP , sufficient to de plete glycogen back down to near control levels by induction of rapid glycogenolysis (Opler and Mak man, 1972; Subbarao and Hertz, 1990) . Exposure to NE and dBcAMP without prior treatment with in sulin or MSO caused little or no increase in neuro nal vulnerability to glucose deprivation. This is con gruent with the small reduction in glycogen induced in these cultures (less than 30 nmol/mg protein) rel ative to the much larger decrease induced in the MSO-and insulin-treated cultures (100 to 125 nmoll mg protein) (Fig. 4) . The minimal injury-poten tiating effects in cultures not preincubated with in sulin or MSO argues against an independent neuro toxic effect of NE or dBcAMP. The negation of the MSO and insulin effects on neuronal survival by exposure to the glycogenolytic agents NE or dB cAMP provides strong evidence that the increased neuronal survival is attributable to increased glial glycogen stores.
We selected conditions for glucose deprivation to maximize the impact of astrocyte energy stores. Glutamine was excluded from the glucose depriva tion medium, as glutamine has been shown to pro long neuronal survival under conditions of glucose deprivation, perhaps by serving as an alternative energy source (Monyer and Choi, 1990) . Secondly, care was taken to reduce the medium glucose con centration to extremely low levels. With a mea sured medium glucose concentration of less than 2 11M in 0.2 ml volume, the amount of glucose present at the onset of glucose deprivation was 0.4 nmoll well. This value is small relative to the glycogen content of the cultures, measured at 5-15 nmol glu cosyl units/well. These measures insured that ef fects of glial glycogen stores would not be swamped by residual glucose in the bathing medium.
Neuronal death during glucose deprivation in vitro has been shown to result in part from over stimulation of NMDA receptors (Monyer et aI., 1989) . Thus one key mechanism by which increased astrocyte glycogen stores may improve neuronal survival under these conditions is by fueling contin ued uptake of released aspartate and glutamate (Sugiyama et al., 1989) ; astrocyte membrane pumps might also help keep local K + concentration down, reducing neuronal excitability. Although the medium volume is very large relative to the cell vol ume, Harris et al. (1989) have shown that neuronal processes and synapses in cortical cultures can be sequestered by glial membranes.
Astrocytes are also known to export metabolic intermediates such as pyruvate and lactate (Passon neau et aI., 1978; Walz and Mukerji, 1988) . These compounds are intermediates of glucose and glyco gen metabolism, and they could potentially be uti lized by neighboring neurons during glucose depri vation or increased energy demand (Selak et aI., 1985; Schurr et al., 1988) . This metabolic interac tion between neurons and glia presents an alterna tive mechanism by which glial glycogen stores might influence neuronal survival. Evidence for this interaction has been demonstrated in retina (Tsaco poulos et aI., 1988) and may represent an important physiologic mechanism in brain (Pentreath et al., 1986) .
Present observations underscore the importance of glial-neuronal interactions under pathological conditions. Numerous agents have been identified as causing increases or decreases in glial glycogen stores, both in culture (Prasannan and Subrahman yam, 1968; Opler and Makman, 1972; Pentreath et aI., 1986; Swanson et aI., 1989 Swanson et aI., , 1990a Subbarao and Hertz, 1990 ) and in vivo (Hutchins and Rogers, 1970; Passonneau et aI., 1971; Gueldry et aI., 1987; Tombaugh et aI., 1992) . In particular, many anes thetic agents increase glial glycogen content (Nel son et aI., 1968; Brunner et aI., 1971) . Many other agents affect plasma or cellular glucose levels, which can in turn affect glial glycogen stores (Pas sonneau et al., 1971; Swanson et aI., 1989) . From a technical standpoint, these interactions may war rant consideration in interpreting the effects of pharmacologic agents or other experimental manip ulations on neuronal survival after substrate limiting insults. Manipulations specifically directed toward improving astrocyte energy status may con stitute useful approaches to reducing certain forms of pathological neuronal injury.
